Triple Antibiotic HC - Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone
Navigation: NDC > Supplier starting with: P > PHOENIX PHARMACEUTICAL, INC.| Field | Value |
|---|---|
| NDC Code: | 57319-344 |
| Proprietary Name: | Triple Antibiotic HC |
| Suffix: | |
| Non-Proprietary Name: | Neomycin sulfate and Polymyxin B Sulfate, Bacitracin Zinc and Hydrocortisone |
| Dosage Form: | OINTMENT |
| Method: | OPHTHALMIC |
| Original Marketing Date: | 30-10-1995 |
| Category Name: | ANDA |
| Application Number: | ANDA064068 |
| Labeler: | PHOENIX PHARMACEUTICAL, INC. |
| Substance Name: | BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Active Numerator Strength: | 400; 10; 3.5; 10000 |
| Active Ingredient Unit: | [USP'U]/g; mg/g; mg/g; [USP'U]/g |
| Pharm Classes: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Decreased Cell Wall Synthesis & Repair [PE],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| DEA Schedule: |